Sunshine Biopharma Sets 1-for-20 Reverse Split to Regain Nasdaq Compliance
The split takes effect at the market open on Oct. 26, 2026, reducing outstanding shares from 15,219,383 to approximately 760,969.
Sunshine Biopharma Inc. said it will implement a 1-for-20 reverse stock split at market open on Oct. 26, 2026, as it seeks to regain compliance with Nasdaq’s minimum bid price requirement. Outstanding shares are expected to decline from 15,219,383 to approximately 760,969.